In NAFLD animal and FFA-treated cell models, overexpression of lncRNA-H19 (H19) promotes steatosis and increases hepatic lipid accumulation and lipogenesis via the miR-130a/PPARγ axis [140]. This evidence concerns the gene PPARG and metabolic dysfunction-associated steatotic liver disease.